Archive for March, 2010

 

TRAP-1 may prevent cancer cell death, current research suggests

March 19th, 2010

Current research suggests that TNF-receptor associated protein-1 (TRAP-1) may prevent cancer cell death. The related report by Leav et al, "Cytoprotective Mitochondrial Chaperone TRAP-1 as a Novel Molecular Target in Localized and Metastatic Prostate Cancer," appears in the January 2010

Read full article   »   Comments Off

Noisy Workplaces Significantly Raise Risk Of Serious Heart Disease

March 18th, 2010

People who work in places where they are exposed to persistently high levels of noise have double the risk of developing serious heart disease compared to employees in other places, say researchers in an article in the peer-reviewed journal Occupational and Environmental Medicine. If the employee is young, male and a smoker the risk is […]

Read full article   »   Comments Off

No Link Found Between Decrease In Suicide And Newer Antidepressants

March 14th, 2010

Many researchers have studied the relationship between the increase in sales of new antidepressants in recent decades and a simultaneous decline in the suicide rate. In a study based on figures from the Nordic countries, researchers at the Norwegian Institute of Public Health found no evidence that increased sales of the new medicines could be […]

Read full article   »   Comments Off

Testosterone To Treat ‘Male Menopause’ Questionable

March 13th, 2010

Given that it is not clear whether male menopause actually exists, and inconclusive evidence on testosterone’s effectiveness in treating it, an article in today’s Drug Therapeutics Bulletin (DTB), a BMJ (British Medical Journal) journal, says that the use of synthetic testosterone is questionable.
Testosterone levels drop by approximately 1% to 2% annually from the age of […]

Read full article   »   Comments Off

Scientific Data Relating To Cinryze(TM) (C1 Esterase Inhibitor [Human]) Presented At International Congress Of The Southern European Allergy Society

March 12th, 2010

ViroPharma Incorporated (Nasdaq: VPHM) announced the presentation of two abstracts relating to Cinryze™ (C1 esterase inhibitor [human]) therapy at the First International Congress of the Southern European Allergy Society in Florence, Italy.
Cinryze was approved by the U.S. Food and Drug Administration in October 2008 for routine prophylaxis against hereditary angioedema (HAE) attacks in adults and […]

Read full article   »   Comments Off

 
Free Web Hosting